Effects of Rosiglitazone with Insulin Combination Therapy on Oxidative Stress and Lipid Profile in Left Ventricular Muscles of Diabetic Rats

Table 1

Blood glucose levels in the study groups.

Weeks
Groups	0	1	2	3	4	5	6	7	8
C (mg/dL)	99.1±1.1	101.2±1.9	102.0±1.7	99.6±1.7	99.1±1.2	98.8±1.7	99.4±1.4	101.1 ± 2.7	100.7 ± 1.6
D (mg/dL)	102.5±1.8	275.8 ± ^*10.0	301.9 ± ^*4.8	306.9 ± ^*10.1	318.5 ± ^*16.3	319.6 ± ^*11.8	321.5 ± ^*9.3	322.2 ± ^*9.7	335.7 ± ^*16.7
B (mg/dL)	92.2±3.1	306.3±7.8	273.5 ± ^†22.7	272.2 ± ^†20.1	262.9 ± ^†18.5	261.5 ± ^†28.2	169.0 ± ^†29.1	200.3 ± ^†12.9	202.1 ± ^†6.4

C: control rats, D: diabetic rat, B: rosiglitazone with insulin combine-treated diabetic rats. Data are presented as mean ± SEM. ^†𝑃<0.05 in B groups compared with D; ^*𝑃<0.05 in D compared with C in the same group in the same week.